Key Insights

Highlights

Success Rate

79% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

12.3%

7 terminated out of 57 trials

Success Rate

79.4%

-7.1% vs benchmark

Late-Stage Pipeline

16%

9 trials in Phase 3/4

Results Transparency

22%

6 of 27 completed with results

Key Signals

6 with results79% success

Data Visualizations

Phase Distribution

38Total
Not Applicable (13)
Early P 1 (1)
P 1 (3)
P 2 (12)
P 3 (2)
P 4 (7)

Trial Status

Completed27
Unknown9
Terminated7
Recruiting6
Not Yet Recruiting5
Active Not Recruiting2

Trial Success Rate

79.4%

Benchmark: 86.5%

Based on 27 completed trials

Clinical Trials (57)

Showing 20 of 20 trials
NCT06286046Phase 2Not Yet Recruiting

A Study of Mitapivat in Participants With Sickle Cell Disease and Nephropathy

NCT06837181Recruiting

Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)

NCT07347769Not Yet RecruitingPrimary

Study of the Serotype and Genotype of BK Virus in Kidney Transplant Recipients and Their Donors to Identify Individuals at Risk of Nephropathy

NCT03620773Phase 1Completed

Impact of Metabolic Surgery on Pancreatic, Renal and Cardiovascular Health in Youth With Type 2 Diabetes

NCT03719339Active Not Recruiting

VIRTUUS Children's Study

NCT07256470Not ApplicableNot Yet Recruiting

Salivary Replication of BK Virus in Post-kidney Transplant

NCT03886714Terminated

Screening for Fabry Disease in Renal Transplantation

NCT06469190Early Phase 1RecruitingPrimary

An Exploratory Clinical Study of Anti-CD19 CAR NK Cell (KN5501) in the Treatment of Relapsed/Refractory Immune Nephropathy

NCT05656261Recruiting

APOL1 Genetic Testing in African Americans

NCT06806644CompletedPrimary

The Role of Ultrasonography in Predicting Outcomes of Fetal Nephropathy

NCT06147232Phase 2Not Yet RecruitingPrimary

Prevention of Chronic Kidney Disease(CDK) Progression in Type 1 Diabetes With Long Term Use of Sodium-Glucose-coTransporter Inhibitors Avoiding Kidney hypOxia

NCT05511779Phase 2Terminated

Study to Confirm of the Safety and Tolerability of Brincidofovir in Subjects With BK Virus Infection (Viremia) After Kidney Transplantation

NCT02675686CompletedPrimary

Amniotic Biomarkers for the Prediction of Postpartum Renal Function.

NCT06501651Phase 4Not Yet Recruiting

Sacubitril/Valsartan Treats Patients With Essential Hypertension and Type 2 Diabetic Nephropathy

NCT06456801CompletedPrimary

Clinical Trial of Anti-PLA2R-IgG Detection Kit (Time-resolved Fluorescence Immunoassay)

NCT02818192Recruiting

Improving Renal Complications in Adolescents With Type 2 Diabetes Through REsearch Cohort Study (National iCARE Study)

NCT05839314Phase 4RecruitingPrimary

Effect of Huaier Granule on the Treatment of Idiopathic Membranous Nephropathy

NCT06355219Completed

Macrovascular and Microvascular Morbidity and Mortality After Metabolic Surgery Versus Medicines

NCT05026021Active Not Recruiting

Prediction of BKvirus Nephropathy Risk by the NEPHROVIR Method in Kidney Transplant Patients With BKvirus Viremia

NCT06325059Not ApplicableRecruitingPrimary

The Role of Renal Progenitors and Polyploid Tubular Cell Response in Glomerular and Tubular Diseases

Scroll to load more

Research Network

Activity Timeline